These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

777 related articles for article (PubMed ID: 26376710)

  • 21. 1.5-T MR relaxometry in quantifying splenic and pancreatic iron: retrospective comparison of a commercial 3D-Dixon sequence and an established 2D multi-gradient echo sequence.
    Plaikner M; Lanser L; Kremser C; Weiss G; Henninger B
    Eur Radiol; 2023 Jul; 33(7):4973-4980. PubMed ID: 36800012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pancreatic iron stores assessed by magnetic resonance imaging (MRI) in beta thalassemic patients.
    de Assis RA; Ribeiro AA; Kay FU; Rosemberg LA; Nomura CH; Loggetto SR; Araujo AS; Fabron Junior A; de Almeida Veríssimo MP; Baldanzi GR; Espósito BP; Baroni RH; Wood JC; Hamerschlak N
    Eur J Radiol; 2012 Jul; 81(7):1465-70. PubMed ID: 21501938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimation of pancreatic R2* for iron overload assessment in the presence of fat: a comparison of different approaches.
    Santarelli MF; Meloni A; De Marchi D; Pistoia L; Quarta A; Spasiano A; Landini L; Pepe A; Positano V
    MAGMA; 2018 Dec; 31(6):757-769. PubMed ID: 30043125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Segmental quantification of hepatic lipid content based on volumetric MRI data in patients with suspected iron overload.
    Wunderlich AP; Cario H; Kannengießer S; Grunau V; Götz M; Hüttner F; Backhus J; Beer M; Schmidt SA
    Rofo; 2024 May; 196(5):463-470. PubMed ID: 38081191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of fatty pancreas by proton density fat fraction using 3-T magnetic resonance imaging and its association with pancreatic cancer.
    Fukui H; Hori M; Fukuda Y; Onishi H; Nakamoto A; Ota T; Ogawa K; Ninomiya K; Tatsumi M; Osuga K; Yamada D; Eguchi H; Miyoshi E; Tomiyama N
    Eur J Radiol; 2019 Sep; 118():25-31. PubMed ID: 31439250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limits of Fat Quantification in the Presence of Iron Overload.
    Colgan TJ; Zhao R; Roberts NT; Hernando D; Reeder SB
    J Magn Reson Imaging; 2021 Oct; 54(4):1166-1174. PubMed ID: 33783066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of Pancreatic Iron Overload Measured by T2*-Weighted Magnetic Resonance Imaging in Diabetic Patients with β-Thalassemia Major.
    Kosaryan M; Rahimi M; Darvishi-Khezri H; Gholizadeh N; Akbarzadeh R; Aliasgharian A
    Hemoglobin; 2017 May; 41(3):151-156. PubMed ID: 28762844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interexamination repeatability and spatial heterogeneity of liver iron and fat quantification using MRI-based multistep adaptive fitting algorithm.
    Sofue K; Mileto A; Dale BM; Zhong X; Bashir MR
    J Magn Reson Imaging; 2015 Nov; 42(5):1281-90. PubMed ID: 25920074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between incidental fat deposition in the liver and pancreas in asymptomatic individuals.
    Aliyari Ghasabeh M; Shaghaghi M; Khoshpouri P; Pan L; Pandy A; Pandy P; Zhong X; Kannengiesser S; Kamel IR
    Abdom Radiol (NY); 2020 Jan; 45(1):203-210. PubMed ID: 31482380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease.
    Inati A; Musallam KM; Wood JC; Sheikh-Taha M; Daou L; Taher AT
    Eur J Haematol; 2009 Dec; 83(6):565-71. PubMed ID: 19737308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3D Multi-Echo Dixon technique for simultaneous assessment of liver steatosis and iron overload in patients with chronic liver diseases: a feasibility study.
    Hu F; Yang R; Huang Z; Wang M; Yuan F; Xia C; Wei Y; Song B
    Quant Imaging Med Surg; 2019 Jun; 9(6):1014-1024. PubMed ID: 31367555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of hepatic steatosis and iron content at 3 Tesla: comparison of two-point Dixon, quantitative multi-echo Dixon, and MR spectroscopy.
    Zhan C; Olsen S; Zhang HC; Kannengiesser S; Chandarana H; Shanbhogue KP
    Abdom Radiol (NY); 2019 Sep; 44(9):3040-3048. PubMed ID: 31286208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease.
    Martí-Aguado D; Jiménez-Pastor A; Alberich-Bayarri Á; Rodríguez-Ortega A; Alfaro-Cervello C; Mestre-Alagarda C; Bauza M; Gallén-Peris A; Valero-Pérez E; Ballester MP; Gimeno-Torres M; Pérez-Girbés A; Benlloch S; Pérez-Rojas J; Puglia V; Ferrández A; Aguilera V; Escudero-García D; Serra MA; Martí-Bonmatí L
    Radiology; 2022 Feb; 302(2):345-354. PubMed ID: 34783592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Automated vessel exclusion technique for quantitative assessment of hepatic iron overload by R2*-MRI.
    Tipirneni-Sajja A; Song R; McCarville MB; Loeffler RB; Hankins JS; Hillenbrand CM
    J Magn Reson Imaging; 2018 Jun; 47(6):1542-1551. PubMed ID: 29083524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of sequential proton density fat fraction for quantification of hepatic steatosis in nonalcoholic fatty liver disease.
    Idilman IS; Keskin O; Elhan AH; Idilman R; Karcaaltincaba M
    Scand J Gastroenterol; 2014 May; 49(5):617-24. PubMed ID: 24694249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pancreatic iron and fat assessment by MRI-R2* in patients with iron overload diseases.
    Pfeifer CD; Schoennagel BP; Grosse R; Wang ZJ; Graessner J; Nielsen P; Adam G; Fischer R; Yamamura J
    J Magn Reson Imaging; 2015 Jul; 42(1):196-203. PubMed ID: 25236606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver R2* is affected by both iron and fat: A dual biopsy-validated study of chronic liver disease.
    Karlsson M; Ekstedt M; Dahlström N; Forsgren MF; Ignatova S; Norén B; Dahlqvist Leinhard O; Kechagias S; Lundberg P
    J Magn Reson Imaging; 2019 Jul; 50(1):325-333. PubMed ID: 30637926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adding liver R2* quantification to proton density fat fraction MRI of vertebral bone marrow improves the prediction of osteoporosis.
    Lu F; Zhao YJ; Ni JM; Jiang Y; Chen FM; Wang ZJ; Zhang ZY
    Eur Radiol; 2022 Oct; 32(10):7108-7116. PubMed ID: 35610386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Standardized Approach for ROI-Based Measurements of Proton Density Fat Fraction and R2* in the Liver.
    Campo CA; Hernando D; Schubert T; Bookwalter CA; Pay AJV; Reeder SB
    AJR Am J Roentgenol; 2017 Sep; 209(3):592-603. PubMed ID: 28705058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of Liver Fat Content With Unenhanced MDCT: Phantom and Clinical Correlation With MRI Proton Density Fat Fraction.
    Pickhardt PJ; Graffy PM; Reeder SB; Hernando D; Li K
    AJR Am J Roentgenol; 2018 Sep; 211(3):W151-W157. PubMed ID: 30016142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.